CRF Health Introduces TrialSlate 1.0.2 Software
Lansdale, PA - December 7, 2009
CRF Health, a provider of electronic Patient Reported Outcomes (ePRO) and wireless data collection solutions for the life sciences industry, has announced the global release of its TrialSlate™1.0.2 Software, an updated version of its TrialSlate application launched earlier this year.
The original TrialSlate application was specifically designed to support larger screen tablet PCs. The Version 1.0.2 expands the TrialSlate’s application’s capabilities with new features including support for the Gigabyte™ T1028X, support for complex script languages, landline support with an external modem, and a new antivirus application.
“Tablet PCs are becoming increasingly popular for ePRO data collection,” notes John Jordan, chief operating officer at CRF Health. “Their larger screens allow them to display many commonly used data instruments in a manner almost identical to their paper-based counterparts, often reducing the need for additional validation. This makes them ideal choices for certain clinical trials.”
The emergence of new and relatively inexpensive netbooks such as the Gigabyte T1028X was a key factor in the development of TrialSlate 1.0.2., said Jordan.
Pekka Keskiivari, chief technical officer at CRF Health, notes that the newly released TrialSlate solution “means more flexibility in supporting different kinds of studies and site environments. TrialSlate can now be used for site-based ePRO in any language, including Middle-Eastern and Indian complex scripts. Study teams can rely on one ePRO solution to cover all countries in global studies.”
Zenocutuzumab Shows Durable Efficacy in NRG1 Fusion-Positive Cancers in Phase II eNRGy Trial
February 13th 2025The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 fusion–positive cancers, particularly non-small cell lung cancer and pancreatic cancer.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.
